Odonate Therapeutics, Inc.
Records under this name other than patents Odonate Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Odonate Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,697,892 | Taxane compounds, compositions and methods Lapsed on the fee record Ended Apr 15, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 15, 2026 | USPTO record |
| US 9,434,740 | Taxane compounds, compositions and methods Lapsed on the fee record Ended Sep 6, 2024 · USPTO record | Lapsed on the fee record | Ended Sep 6, 2024 | USPTO record |
| US 9,284,327 | Taxane compounds, compositions and methods Lapsed on the fee record Ended Mar 15, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2024 | USPTO record |
| US 7,842,724 | Pharmaceutical gallium compositions and methods Lapsed on the fee record Ended Nov 30, 2022 · USPTO record | Lapsed on the fee record | Ended Nov 30, 2022 | USPTO record |
| US 8,785,669 | Taxane Compounds, Compositions And Methods Lapsed on the fee record Ended Jul 22, 2022 · High confidence | Lapsed on the fee record | Ended Jul 22, 2022 | High confidence |
| US 5,606,049 | Method of preparing 2'-O-methyl cytidine monomers useful in oligomer synthesis Term ended Term ended no later than Feb 25, 2017 · Low confidence | Term ended | Term ended no later than Feb 25, 2017 | Low confidence |